FDA Inspection
GlaxoSmithKline Manufacturing S.p.A.GlaxoSmithKline Manufacturing S.p.A. – FDA Inspection, May 15, 2025
Record Details
This FDA Inspection record concerns GlaxoSmithKline Manufacturing S.p.A., with an inspection on May 15, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 6fee4446-b8f0-4691-a877-618dc26c742b
Inspection Facts
- Inspection number
- 1285374
- FDA center
- Human Drugs
Other FDA inspections of GlaxoSmithKline Manufacturing S.p.A.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| October 26, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 29, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 22, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 27, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 10, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for GlaxoSmithKline Manufacturing S.p.A.
- FDA Inspection 1244033 - 2023-10-26
- FDA Inspection 1064045 - 2017-09-29
- FDA Inspection 982333 - 2016-07-22
- FDA Inspection 934049 - 2015-05-27
- FDA Inspection 842545 - 2013-07-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.